For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

GSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...

Most internal ventures fail not from bad ideas, but bad design. Learn how future-focused leaders are building smarter systems ...